Table 1 Characteristics of the study population
Variable | Total (n = 245)* |
|---|---|
Age, years | 51.2 (12.3) |
Male gender, n (%) | 153 (62.4) |
High education, n (%)† | 80 (32.7) |
Currently employed, n (%) | 139 (56.7) |
High income, n (%)‡ | 95 (38.8) |
SRPQ (satisfaction, 1–5) | 3.2 (0.8) |
Mastery (7–28) | 20.7 (3.9) |
Comorbidity (SCQ) | 3.1 (4.3) |
History of depression, n (%) | 9 (3.7) |
Disease duration, years | 23.6 (13.3) |
History of any EAM, n (%) | 78 (31.8) |
History of psoriasis, n (%) | 20 (8.2) |
History of IBD, n (%) | 33 (13.5) |
History of uveitis, n (%) | 44 (18.0) |
NSAID use, n (%) | 134 (54.7) |
Biological use, n (%) | 125 (51.0) |
BASDAI (0–10) | 4.4 (2.3) |
BASFI (0–10) | 4.2 (2.6) |
Patient global (0–10) | 4.8 (2.7) |
SF36-PCS (0–100) | 38.8 (10.8) |
SF36-MCS (0–100) | 49.2 (12.8) |
HADS-depression (0–21) | 4.1 (3.7) |